Abstract
Hydroxychloroquine, first introduced as an antimalarial drug in 1955, has been widely used along with corticosteroids and other immunomodulatory agents to treat a variety of connective tissue diseases. However, it affects lysosomal function which can result in the development of a vacuolar myopathy, characterized by the presence of autophagic rimmed vacuoles and distinctive curvilinear bodies and myeloid profiles. Patients with hydroxychloroquine myopathy often present with proximal limb weakness which can progress into diffuse weakness and respiratory failure. Muscle biopsy is essential to differentiate hydroxychloroquine myopathy from steroid myopathy and inflammatory myopathies associated with connective tissue diseases. Here we present a case with clinical presentation and muscle biopsy features consistent with hydroxychloroquine myopathy. The patient had a near-complete recovery 2 months after discontinuing hydroxychloroquine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69(1):20–8.
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762–84.
Tang C, Godfrey T, Stawell R, Nikpour M. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. Intern Med J. 2012;42(9):968–78.
Fox RI. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum. 1993;23(2 Suppl 1):82–91.
Stauber WT, Hedge AM, Trout JJ, Schottelius BA. Inhibition of lysosomal function in red and white skeletal muscles by chloroquine. Exp Neurol. 1981;71(2):295–306.
McChesney EW. Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med. 1983;75(1A):11–8.
Finbloom DS, Silver K, Newsome DA, Gunkel R. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol. 1985;12(4):692–4.
Scherbel AL, Schuchter SL, Harrison JW. Comparison of effects of two antimalarial agents, hydroxychloroquine sulfate and chloroquine phosphate, in patients with rheumatoid arthitis. Cleve Clin Q. 1957;24(2):98–104.
Sundelin SP, Terman A. Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS. 2002;110(6):481–9.
Stein M, Bell MJ, Ang LC. Hydroxychloroquine neuromyotoxicity. J Rheumatol. 2000;27(12):2927–31.
Khoo T, Otto S, Smith C, Koszyca B, Lester S, Blumbergs P, et al. Curvilinear bodies are associated with adverse effects on muscle function but not with hydroxychloroquine dosing. Clin Rheumatol. 2017;36(3):689–93.
Abdel-Hamid H, Oddis CV, Lacomis D. Severe hydroxychloroquine myopathy. Muscle Nerve. 2008;38(3):1206–10.
Bolanos-Meade J, Zhou L, Hoke A, Corse A, Vogelsang G, Wagner KR. Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease. Am J Hematol. 2005;78(4):306–9.
Siddiqui AK, Huberfeld SI, Weidenheim KM, Einberg KR, Efferen LS. Hydroxychloroquine-induced toxic myopathy causing respiratory failure. Chest. 2007;131(2):588–90.
Neville HE, Maunder-Sewry CA, McDougall J, Sewell JR, Dubowitz V. Chloroquine-induced cytosomes with curvilinear profiles in muscle. Muscle Nerve. 1979;2(5):376–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zhou, L., Burns, D.K. (2020). A 42-Year-Old Woman with Progressive Limb Weakness and Breathing Difficulty. In: Zhou, L., Burns, D., Cai, C. (eds) A Case-Based Guide to Neuromuscular Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-25682-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-25682-1_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25681-4
Online ISBN: 978-3-030-25682-1
eBook Packages: MedicineMedicine (R0)